Published in J Neurol Neurosurg Psychiatry on March 01, 2003
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
The Rotterdam Study: objectives and design update. Eur J Epidemiol (2007) 5.78
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44
The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26
Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke (2009) 3.23
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol (2013) 2.56
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci U S A (2009) 2.15
Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ (2008) 2.01
Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ (2005) 1.84
An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea. Sleep (2011) 1.80
Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. Stroke (2011) 1.78
The effect of survival bias on case-control genetic association studies of highly lethal diseases. Circ Cardiovasc Genet (2011) 1.71
The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol (2015) 1.61
Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics (2011) 1.16
Families Enriched for Exceptional Longevity also have Increased Health-Span: Findings from the Long Life Family Study. Front Public Health (2013) 1.11
Stroke risk in women: the role of menopause and hormone therapy. Lancet Neurol (2012) 1.10
Perceived wellbeing of patients one year post stroke in general practice--recommendations for quality aftercare. BMC Neurol (2011) 1.03
Age-specific trends in morbidity, mortality and case-fatality from cardiovascular disease, myocardial infarction and stroke in advanced age: evaluation in the Swedish population. PLoS One (2013) 1.03
Sex-related time-dependent variations in post-stroke survival--evidence of a female stroke survival advantage. Neuroepidemiology (2007) 0.99
Neuroprotection of sex steroids. Minerva Endocrinol (2010) 0.99
Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study. Br J Cancer (2011) 0.97
Interactions between age, sex, and hormones in experimental ischemic stroke. Neurochem Int (2012) 0.96
Biological sex and mechanisms of ischemic brain injury. Transl Stroke Res (2013) 0.96
Age-dependent effects of testosterone in experimental stroke. J Cereb Blood Flow Metab (2008) 0.92
Gender differences in pediatric stroke: is elevated testosterone a risk factor for boys? Ann Neurol (2009) 0.92
Trends in Acute Ischemic Stroke Hospitalizations in the United States. J Am Heart Assoc (2016) 0.91
Self-Management Support Interventions for Stroke Survivors: A Systematic Meta-Review. PLoS One (2015) 0.89
Stroke incidence and association with risk factors in women: a 32-year follow-up of the Prospective Population Study of Women in Gothenburg. BMJ Open (2014) 0.88
Sex shapes experimental ischemic brain injury. Steroids (2009) 0.88
Role of salt-induced kinase 1 in androgen neuroprotection against cerebral ischemia. J Cereb Blood Flow Metab (2010) 0.88
Neonatal testosterone exposure protects adult male rats from stroke. Neuroendocrinology (2012) 0.87
Predictors of 30-day mortality and 90-day functional recovery after primary intracerebral hemorrhage : hospital based multivariate analysis in 585 patients. J Korean Neurosurg Soc (2009) 0.87
Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly. J Cereb Blood Flow Metab (2011) 0.86
Oxidative stress defines the neuroprotective or neurotoxic properties of androgens in immortalized female rat dopaminergic neuronal cells. Endocrinology (2013) 0.83
Poor outcome in primary intracerebral haemorrhage: results of a matched comparison. Postgrad Med J (2004) 0.83
Age- and ethnic-specific sex differences in stroke risk. Gend Med (2012) 0.83
Carotid intima-media thickness is associated with cognitive deficiency in hypertensive patients with elevated central systolic blood pressure. Cardiovasc Ultrasound (2012) 0.82
Long-Term Cost-Effectiveness of Upper Airway Stimulation for the Treatment of Obstructive Sleep Apnea: A Model-Based Projection Based on the STAR Trial. Sleep (2015) 0.82
Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion. Horm Behav (2011) 0.81
Risk of stroke after chiropractic spinal manipulation in medicare B beneficiaries aged 66 to 99 years with neck pain. J Manipulative Physiol Ther (2015) 0.80
Survival and quality of life outcome after mechanical ventilation in elderly stroke patients. J Neurol Neurosurg Psychiatry (2004) 0.80
Co-Occurrence of Arthritis and Stroke amongst Middle-Aged and Older Adults in Canada. Stroke Res Treat (2014) 0.79
Androgens and stroke: good, bad or indifferent? Exp Neurol (2014) 0.78
Retrospective case review of missed opportunities for primary prevention of stroke and TIA in primary care: protocol paper. BMJ Open (2014) 0.77
Impact of genetic testing on complex diseases. Eur J Epidemiol (2005) 0.77
Time series analysis of the association between ambient temperature and cerebrovascular morbidity in the elderly in Shanghai, China. Sci Rep (2016) 0.77
Assessing the burden of medical impoverishment by cause: a systematic breakdown by disease in Ethiopia. BMC Med (2016) 0.75
Association of dementia with death after ischemic stroke: A two-year prospective study. Exp Ther Med (2016) 0.75
[Lipid and glucose profile in patients with ischemic cerebrovascular accidents in Dakar]. Pan Afr Med J (2016) 0.75
Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients. Clin Res Cardiol (2016) 0.75
Testosterone Propionate Exacerbates the Deficits of Nigrostriatal Dopaminergic System and Downregulates Nrf2 Expression in Reserpine-Treated Aged Male Rats. Front Aging Neurosci (2017) 0.75
Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol (1991) 7.67
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry (1988) 4.98
Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 4.13
Epidemiology of stroke. Lancet (1992) 3.33
Secular trends in stroke incidence and mortality. The Framingham Study. Stroke (1992) 2.07
Geographical and secular trends in stroke incidence. Lancet (1987) 1.94
A prospective community-based study of stroke in Germany--the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke (1998) 1.62
Epidemiology of stroke in Innherred, Norway, 1994 to 1996. Incidence and 30-day case-fatality rate. Stroke (1997) 1.58
Stroke incidence on the east coast of Australia: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke (2000) 1.48
Changes in stroke incidence and case-fatality in Auckland, New Zealand, 1981-91. Lancet (1993) 1.46
Variations in stroke incidence and survival in 3 areas of Europe. European Registries of Stroke (EROS) Collaboration. Stroke (2000) 1.41
Prevalence of stroke in the general population. The Rotterdam Study. Stroke (1996) 1.36
Incidence and prognosis of stroke in the Belluno province, Italy. First-year results of a community-based study. Stroke (1995) 1.14
Stroke incidence and case fatality in southern Greece: the Arcadia stroke registry. Stroke (1999) 1.13
Prognosis of stroke in the south of Greece: 1 year mortality, functional outcome and its determinants: the Arcadia Stroke Registry. J Neurol Neurosurg Psychiatry (2000) 1.06
Time trends, cohort effects, and geographic patterns in stroke mortality--United States. Ann Epidemiol (1993) 1.05
Community-based stroke incidence trends from the 1970s through the 1980s in East Germany. Stroke (1995) 1.05
SEPIVAC: a community-based study of stroke incidence in Umbria, Italy. J Neurol Neurosurg Psychiatry (1991) 1.00
Stroke incidence and 30-day case-fatality rates in Novosibirsk, Russia, 1982 through 1992. Stroke (1995) 0.94
Stroke trends in Rochester, Minnesota, during 1945 to 1984. Ann Epidemiol (1993) 0.90
Frequency of stroke in Europe: A collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on Aging. Neurology (2000) 0.89
Monitoring stroke. An international challenge. Stroke (1995) 0.89
A prospective community-based study of stroke in Warsaw, Poland. Stroke (1994) 0.85
Stroke trends in Australia and New Zealand: mortality, morbidity, and risk factors. Ann Epidemiol (1993) 0.85
The enigma of the decline in stroke deaths in the United States: the search for an explanation. Stroke (1996) 0.85
Changed incidence and case-fatality rates of first-ever stroke between 1970 and 1993 in Tartu, Estonia. Stroke (1996) 0.85
Stroke incidence and case fatality in two populations: the Auckland Stroke Study and the Copenhagen City Heart Study. Neuroepidemiology (1998) 0.84
Ethnic differences in stroke incidence and case fatality in Auckland, New Zealand. Stroke (1997) 0.83
Decline in stroke mortality in North Carolina. Description, predictions, and a possible underlying cause. Ann Epidemiol (1993) 0.81
Trends in stroke mortality and incidence in Finland in the 1970s and 1980s. Ann Epidemiol (1993) 0.80
Delayed arteriosclerosis progression in high risk subjects treated with mesoglycan. Evaluation of intima-media thickness. J Cardiovasc Surg (Torino) (1993) 0.80
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1988) 20.14
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol (1991) 7.67
Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology (1999) 7.55
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12
The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04
Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med (2000) 5.02
Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol (1998) 4.91
Cardiovascular mortality in Dutch men during 1996 European football championship: longitudinal population study. BMJ (2001) 4.87
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
The epidemiology of heart failure. Eur Heart J (1997) 4.31
Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99
Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation (2001) 3.96
J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet (1994) 3.95
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 3.76
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension (1999) 3.51
External validation is necessary in prediction research: a clinical example. J Clin Epidemiol (2003) 3.49
Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology (2012) 3.47
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol (1999) 3.44
Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37
The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology (1994) 3.30
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet (1998) 3.26
Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study. Invest Ophthalmol Vis Sci (2000) 3.19
Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J (1999) 3.18
The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J (2001) 3.07
Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation (2005) 2.99
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol (1996) 2.80
Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology (2001) 2.80
Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2008) 2.72
Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia (2003) 2.66
Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet (1994) 2.65
Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med (1998) 2.64
Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann Rheum Dis (2011) 2.61
Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ (1994) 2.60
C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation (2005) 2.59
A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord (2001) 2.55
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke (2001) 2.49